Enablex

Active Ingredient(s): Darifenacin
FDA Approved: * December 22, 2004
Pharm Company: * NOVARTIS
Category: Urinary System

Darifenacin (trade name Enablex in United States and Canada, Emselex in the European Union) is a medication used to treat urinary incontinence due to an overactive bladder.[1][2][3] It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier UK-88,525 and used to be marketed by Novartis. In 2010, the US rights were sold to Warner Chilcott for US$400 million. Contents 1 Adverse effects 2 Medical uses 3 Mecha... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
8 Discussions

Dosage List

Enablex DF;7;5
24 Hr Enablex 7.5 mg Extended Release Tablet
NDC: 0078-0419
Labeler:
Novartis Pharmaceuticals Corporation
Enablex DF;15
Enablex 15 mg 24 Hr Extended Release Tablet
NDC: 0078-0420
Labeler:
Novartis Pharmaceuticals Corporation
Enablex DF;7;5
24 Hr Enablex 7.5 mg Extended Release Tablet
NDC: 0430-0170
Labeler:
Warner Chilcott (Us), LLC
Enablex DF;15
Enablex 15 mg 24 Hr Extended Release Tablet
NDC: 0430-0171
Labeler:
Warner Chilcott (Us), LLC
Enablex DF;15
Enablex 15 mg 24 Hr Extended Release Tablet
NDC: 35356-272
Labeler:
Lake Erie Medical & Surgical Supply Dba Quality Care Products LLC
Enablex DF;15
Enablex 15 mg 24 Hr Extended Release Tablet
NDC: 54868-5363
Labeler:
Physicians Total Care, Inc.
Enablex DF;7;5
24 Hr Enablex 7.5 mg Extended Release Tablet
NDC: 54868-5704
Labeler:
Physicians Total Care, Inc.

Popular Topics

Enablex-darifenacin

Prostate Condition...

Enablex 7.5 mg.

Prescribed for bladder spammes...

enablex incontence

enablex...